These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24797260)

  • 21. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.
    Wang J; Liao L; Tan J
    Expert Opin Biol Ther; 2011 Jul; 11(7):893-909. PubMed ID: 21449634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Systematic Review of Clinical Studies Investigating Mesenchymal Stem Cells for Fracture Non-Union and Bone Defects.
    Killington K; Mafi R; Mafi P; Khan WS
    Curr Stem Cell Res Ther; 2018; 13(4):284-291. PubMed ID: 28914208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?
    Millard SM; Fisk NM
    Bioessays; 2013 Mar; 35(3):173-82. PubMed ID: 23184477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stem cells in regenerative medicine: a new paradigm for degenerative bone diseases.
    Shyam H; Singh SK; Kant R; Saxena SK
    Regen Med; 2017 Mar; 12(2):111-114. PubMed ID: 28244826
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of microenvironment in mesenchymal stem cell-based regeneration of intervertebral disc.
    Huang YC; Leung VY; Lu WW; Luk KD
    Spine J; 2013 Mar; 13(3):352-62. PubMed ID: 23340343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of osteoarthritis with mesenchymal stem cells.
    Wang W; Cao W
    Sci China Life Sci; 2014 Jun; 57(6):586-95. PubMed ID: 24849513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of cell-based therapy in lung diseases.
    Huleihel L; Levine M; Rojas M
    Expert Opin Biol Ther; 2013 Oct; 13(10):1429-40. PubMed ID: 23984902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial progenitor cells improve directly and indirectly early vascularization of mesenchymal stem cell-driven bone regeneration in a critical bone defect in rats.
    Seebach C; Henrich D; Wilhelm K; Barker JH; Marzi I
    Cell Transplant; 2012; 21(8):1667-77. PubMed ID: 22507568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stromal cell injection protects against oxidative stress in Escherichia coli-induced acute lung injury in mice.
    Shalaby SM; El-Shal AS; Abd-Allah SH; Selim AO; Selim SA; Gouda ZA; Abd El Motteleb DM; Zanfaly HE; El-Assar HM; Abdelazim S
    Cytotherapy; 2014 Jun; 16(6):764-75. PubMed ID: 24525173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
    Bouffi C; Djouad F; Mathieu M; Noël D; Jorgensen C
    Rheumatology (Oxford); 2009 Oct; 48(10):1185-9. PubMed ID: 19561159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cell treatment for autoimmune diseases: a critical review.
    Figueroa FE; Carrión F; Villanueva S; Khoury M
    Biol Res; 2012; 45(3):269-77. PubMed ID: 23283436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential therapeutic applications of mesenchymal stromal cells.
    Larsen S; Lewis ID
    Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cells in bone diseases: current clinical practice.
    Beyth S; Schroeder J; Liebergall M
    Br Med Bull; 2011; 99():199-210. PubMed ID: 21813557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells in regenerative medicine for musculoskeletal diseases: bench, bedside, and industry.
    Wei CC; Lin AB; Hung SC
    Cell Transplant; 2014; 23(4-5):505-12. PubMed ID: 24816447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report.
    Renzi S; Riccò S; Dotti S; Sesso L; Grolli S; Cornali M; Carlin S; Patruno M; Cinotti S; Ferrari M
    Res Vet Sci; 2013 Aug; 95(1):272-7. PubMed ID: 23419936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.
    Lange-Consiglio A; Tassan S; Corradetti B; Meucci A; Perego R; Bizzaro D; Cremonesi F
    Cytotherapy; 2013 Aug; 15(8):1011-20. PubMed ID: 23602577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy.
    Naderi-Meshkin H; Bahrami AR; Bidkhori HR; Mirahmadi M; Ahmadiankia N
    Cell Biol Int; 2015 Jan; 39(1):23-34. PubMed ID: 25231104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stromal cell therapy: different sources exhibit different immunobiological properties.
    Neofytou E; Deuse T; Beygui RE; Schrepfer S
    Transplantation; 2015 Jun; 99(6):1113-8. PubMed ID: 26035274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.